SCHEMBL18256294

SCHEMBL18256294

CCOc1ccc(C#Cc2ccc(CC(C)NC(N)=O)cc2)cc1

nearest known ligand 0.79

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
ACACB O00763 20/20 0.79

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL256142 0.88 ACACB (1.00) ACACB
SCHEMBL164279 0.88 ACACB (1.00) ACACB
SCHEMBL10187732 0.88 ACACB (1.00) ACACB
SCHEMBL11998551 0.87 ACACB (1.00) ACACB
SCHEMBL255814 0.87 ACACB (1.00) ACACB
SCHEMBL173447 0.87 ACACB (1.00) ACACB
SCHEMBL11998554 0.86 ACACB (1.00) ACACB
SCHEMBL256145 0.85 ACACB (0.84) ACACB
SCHEMBL256112 0.85 ACACB (1.00) ACACB
SCHEMBL256866 0.85 ACACB (1.00) ACACB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2611771-B1 SUBSTITUTED HETEROARYL- AND ARYLALKYNYL BENZENE DERIVATIVES AS ACC-INHIBITORS FOR THE TREATMENT OF METABOLIC DISEASES BOEHRINGER INGELHEIM INT (DE) 2016-11-23 EP disclosed